Home
E-submission
Sitemap
Contact us
HOME
ABOUT
Aims and scope
About the journal
About the society
Editorial board
Managing team
Best practice
Metrics
Contact us
ARTICLE CATEGORY
Original article
Review
Case report
Technical note
Brief communication
Guideline
Editorial
Letter to the editor
Video
Others
Browse all articles >
BROWSE ARTICLES
Accepted Articles
Ahead-of print
Current issue
All issues
Most view
Most download
Most cited
Funded articles
Ann Coloproctol Search
Author index
ACP Abstract book
EDITORIAL POLICY
Review policy
Open access
Advertising policy
Others
- Data sharing policy
- Data archiving policy
- Crossmark
FOR CONTRIBUTORS
FOR AUTHORS
- Instructions for authors
- Instructions for uploading manuscriptsfor electronic review
- Review flow
- Article processing charge
- Author’s checklist
- Copyright transfer agreement
- E-submission
FOR REVIEWERS
- Instructions to reviewers
- How to become a reviewer?
FOR READERS
Open access
Subscription information
TOC alerts
Permission request
Search
Ann Coloproctol Search
CLOSE
Search
Page Path
HOME
Search
Evaluation of a Seton Procedure Combined With Infliximab Therapy (Early vs. Late) in Perianal Fistula With Crohn Disease
Myunghoon Jeon, Kihwan Song, Jail Koo, Sohyun Kim
Ann Coloproctol.
2019;35(5):249-253. Published online October 31, 2019
DOI:
https://doi.org/10.3393/ac.2018.11.23.1
Cited By 7
Abstract
Full text
PubReader
ePub
Crossref - TDM
PDF
Abstract
Purpose
We assessed the clinical outcomes of a seton procedure combined with early versus late institution of infliximab (IFX) therapy.
Methods
This retrospective study comprised 76 patients who underwent surgery for perianal fistula associated with Crohn disease between January 2014 and November 2017. All patients underwent loose seton drainage combined with IFX therapy. Patients categorized as the early group (EG, 49 patients) received IFX therapy within 30 days of completion of the seton procedure. Patients categorized as the late group (LG, 27 patients) received IFX therapy >30 days after the seton procedure. IFX therapy was administered as induction and maintenance therapy.
Results
There were no statistically significant intergroup differences in clinical characteristics of the patients. The mean follow-up was 21.0 ± 11.6 months in the EG and 34.5 ± 18.4 months in the LG (P = 0.001). The mean interval between seton procedure and IFX induction therapy was 12.2 days in the EG and 250.2 days in the LG (P = 0.002). Complete remission was observed in 32 patients (65.3%) in the EG and 17 patients (63.0%) in the LG (P = 0.844). Fistula recurrence was observed in 6 patients (7.9%). All recurrences occurred in a previous perianal fistula tract.
Conclusion
Patients showed a good response to a seton procedure combined with IFX therapy regardless of the time of initiation of IFX therapy.
1
Double-layered hand-sewn anastomosis: a valuable resource for the colorectal surgeon. Ann Coloproctol. 2022;38:271-275
ABOUT
Aims and scope
About the journal
About the society
Editorial board
Managing team
Best practice
Metrics
Contact us
ARTICLE CATEGORY
Original article
Review
Case report
Technical note
Brief communication
Guideline
Editorial
Letter to the editor
Video
Others
Browse all articles >
BROWSE ARTICLES
Accepted Articles
Ahead-of print
Current issue
All issues
Most view
Most download
Most cited
Funded articles
Ann Coloproctol Search
Author index
ACP Abstract book
AUTHOR INFORMATION
FOR AUTHORS
- Instructions for authors
- Instructions for uploading manuscriptsfor electronic review
- Review flow
- Article processing charge
- Author’s checklist
- Copyright transfer agreement
- E-submission
FOR REVIEWERS
- Instructions to reviewers
- How to become a reviewer?